Table 4.
Metabolic parameters of the study participants at the beginning of the study.
| Characteristics | PRO Group | PLC Group | p |
|---|---|---|---|
| Weight (kg) | 71.95 ± 17.26 | 70.92 ± 17.26 | 0.99 |
| BMI (kg/m2) | 24.29 ± 3.41 | 25.77 ± 5.98 | 0.49 |
| WC * (cm) | 86.46 ± 11.76 | 86.60 ± 15.85 | 0.90 |
| sBP * (mmHg) | 122.48 ± 16.77 | 120.19 ± 18.22 | 0.53 |
| dBP * (mmHg) | 83.28 ± 10.22 | 81.52 ± 9.38 | 0.66 |
| fGlc * (mmol/l) | 5.22 ± 0.54 | 5.09 ± 0.44 | 0.53 |
| HDL-c * (mmol/l) | 1.67 ± 0.46 | 1.56 ± 0.30 | 0.43 |
| TG * (mmol/l) | 1.19 ± 0.68 | 1.35 ± 0.52 | 0.10 |
| TG/HDL-c | 0.80 ± 0.56 | 0.95 ± 0.48 | 0.11 |
| AST (U/l) | 24.69 ± 6.17 | 24.27 ± 10.01 | 0.44 |
| ALT (U/l) | 22.52 ± 15.79 | 21.28 ± 16.28 | 0.83 |
| AST/ALT | 1.36 ± 0.49 | 1.32 ± 0.41 | 0.95 |
| APRI | 0.27 ± 0.10 | 0.25 ± 0.10 | 0.29 |
| FIB-4 | 0.73 ± 0.38 | 0.72 ± 0.36 | 0.93 |
BMI: body mass index; WC: waist circumference; sBP: systolic blood pressure; dBP: diastolic blood pressure; fGlc: fasting glucose; HDL-c: high-density lipoprotein cholesterol; TG: triglicerides; AST: aspartate aminotransferase; ALT: alanine aminotransferase; APRI: AST/PLT ratio index; FIB-4: Fibrosis-4; *: metabolic syndrome criteria components.